BackUsana Health Sciences Overview

Usana Health Sciences Receivables

Track Usana Health Sciences's receivables ($9.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$9.66M

Peer average / median

Loading

Usana Health Sciences Receivables History

Loading

Usana Health Sciences vs. peers: Receivables Comparison

Loading

Usana Health Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Usana Health Sciences (USNA) FAQ

Usana Health Sciences (USNA) currently reports a receivables of $9.7M as of April 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Usana Health Sciences's receivables history and peer comparisons.

Usana Health Sciences's receivables changed from $0 to $9.7M (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Usana Health Sciences reported $9.7M in receivables as of April 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $9.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Usana Health Sciences, and consider following USNA for alerts when major investors trade the stock.

Usana Health Sciences is classified in the Healthcare sector. On receivables, it currently shows $9.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing USNA with unrelated industries.